This Obesity Drug Stock Surges 60% on Phase 3 News
A notable fund sold millions of dollars’ worth of shares as this obesity drug stock jumped on Phase 3 momentum. Here’...
Utilize your professional skills to create additional income streams. Discover practical ways to monetize your expertise and improve your finances.
17,916 articlesA notable fund sold millions of dollars’ worth of shares as this obesity drug stock jumped on Phase 3 momentum. Here’...
A renewed focus on energy equities is lifting parts of the market today. This piece breaks down what’s driving the mo...
California’s CEQA exemption is speeding residential projects, yet fault lines surface as opponents deploy new delay t...
XRP trades in a tight band around $1.40 as traders weigh regulatory progress, ETF flows, and Bitcoin momentum. This r...
Allbirds’ shares soared 600% after a vague pivot to AI, prompting questions about hype versus substance in AI claims ...
A civil suit over a $100 million claim has escalated into a courtroom confrontation between Galaxy Digital founder Mi...
Senate rebukes Trump-era spending as GOP dissent grows, delaying a roughly $70 billion budget package and stirring ma...
Texas’ GOP Senate runoff pits Sen. John Cornyn against Ken Paxton as Trump weighs in, boosting a race already fueled ...
Ripple pushes deeper into institutional finance as banks sign on to new settlement rails, even as XRP traders retreat...
SpaceX's planned NASDAQ debut includes two pivotal admissions that could influence investor risk assessments: Starshi...
Natera shows growth through AI-enabled cell-free DNA tests and a widening data moat, positioning it as a leading nate...
In 2026, nuclear energy climbs back into the spotlight as AI-driven electricity demand surges. This article lays out ...